We focus on 4 sectors:
01 / 04
Outcomes in development
How we do it
Deep expertise and partnerships with industry leaders
The best founders and a proven methodology
De-risked ventures and world-class investors
Creating a Thriving Future
28 July 2022
Unlocking a post-Moore's Law approach to computing
29 July 2022
Outcomes Graph: A protocol for applied science coordination
28 September 2022
We need to make atoms-based entrepreneurship cool again
06 March 2023
Leading Cancer Biologists and Entrepreneurs Join Enedra Therapeutics as Co-Founders
Enedra Therapeutics, a therapeutics company within the Deep Science Ventures portfolio, announces that it is adding a number of seasoned industry executives as co-founders, bringing extensive expertise in cancer biology, drug discovery and corporate strategy to the team.
12 April 2023
Why are there no cures for inflammatory disease – and can tolerance solve it?
Despite tremendous unmet need, there are still no cures for inflammatory disease. Existing therapies fail for known reasons – yet nobody has thus far created therapeutics that fulfil all the necessary requirements. We need to find ways to turn off the causal upstream sources of inflammation rather than simply mopping up downstream inflammatory signals.
31 March 2023